NCT00246909 · Interventional trial
Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)
Overall registry status Completed
Phase 4
Conditions Gastroesophageal Reflux
Delaware Valley sites
- Altana Pharma/Nycomed · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory